Original article
Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implications
Seguridad de los anticuerpos monoclonales anti-CGRP en pacientes con migraña durante la pandemia de COVID-19: implicaciones actuales y futuras
E. Caronnaa,b, V. José Gallardob, A. Alpuentea,b, M. Torres-Ferrusa,b, N.M. Sánchez-Mateoc, J. Viguera-Romerod, A.C. López-Velosoe, A. López-Bravof, A.B. Gago-Veigag, P. Irimia Sieirah, J. Porta-Etessami, S. Santos-Lasaosaj, P. Pozo-Rosicha,b,
, Spanish CGRP-COVID Study Group
Corresponding author
a Headache Unit, Neurology Department, Hospital Universitari Vall d’Hebron, Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain
b Headache and Neurological Pain Research Group, Vall d’Hebron Research Institute, Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain
c Headache Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
d Headache Unit, Neuroscience Department, Hospital Universitario Virgen Macarena, Sevilla, Spain
e Neurology Department, Hospital Universitario de Gran Canaria Dr. Negrín, Gran Canaria, Spain
f Neurology Department, Hospital Reina Sofia, Tudela, Spain
g Headache Unit, Neurology Department, Hospital Universitario de La Princesa & Instituto de Investigación Sanitaria de La Princesa, Madrid, Spain
h Neurology Department, Clinica Universidad de Navarra, Pamplona, Spain
i Department of Neurology, Institute of Neurosciences, Hospital Clínico San Carlos, IdISSC, Universidad Complutense de Madrid, Madrid, Spain
j Headache Unit, Neurology Department, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain
Ver másRead
2065
Timeswas read the article
376
Total PDF
1689
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 December | 23 | 1 | 24 |
| 2024 November | 26 | 8 | 34 |
| 2024 October | 16 | 12 | 28 |
| 2024 September | 42 | 2 | 44 |
| 2024 August | 34 | 3 | 37 |
| 2024 July | 53 | 3 | 56 |
| 2024 June | 38 | 3 | 41 |
| 2024 May | 25 | 4 | 29 |
| 2024 April | 26 | 10 | 36 |
| 2024 March | 76 | 3 | 79 |
| 2024 February | 53 | 11 | 64 |
| 2024 January | 24 | 5 | 29 |
| 2023 December | 39 | 12 | 51 |
| 2023 November | 48 | 3 | 51 |
| 2023 October | 54 | 11 | 65 |
| 2023 September | 38 | 5 | 43 |
| 2023 August | 19 | 9 | 28 |
| 2023 July | 15 | 7 | 22 |
| 2023 June | 29 | 3 | 32 |
| 2023 May | 20 | 1 | 21 |
| 2023 April | 33 | 8 | 41 |
| 2023 March | 26 | 5 | 31 |
| 2023 February | 21 | 0 | 21 |
| 2023 January | 19 | 10 | 29 |
| 2022 December | 60 | 3 | 63 |
| 2022 November | 35 | 10 | 45 |
| 2022 October | 34 | 9 | 43 |
| 2022 September | 32 | 8 | 40 |
| 2022 August | 35 | 12 | 47 |
| 2022 July | 30 | 6 | 36 |
| 2022 June | 43 | 19 | 62 |
| 2022 May | 49 | 17 | 66 |
| 2022 April | 74 | 20 | 94 |
| 2022 March | 94 | 31 | 125 |
| 2022 February | 69 | 15 | 84 |
| 2022 January | 129 | 18 | 147 |
| 2021 December | 68 | 26 | 94 |
| 2021 November | 83 | 26 | 109 |
| 2021 October | 57 | 17 | 74 |
Show all
